Skip to main content
. 2024 Jan 11;12(3):54. doi: 10.21037/atm-23-1589

Figure 2.

Figure 2

(A) The studies with number of patients per each study on cases with periorbital BCC treated with vismodegib. (B) Classification of all studies on cases with periorbital BCC treated with vismodegib based on gender. (C) Classification of studies based on the metastasis. BCC, basal cell carcinoma.